Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Patent and Trademark Office has issued a new patent to Vasomedical for technology that automatically controls and maintains the inflation and deflation pressures within the cuffs during enhanced external counterpulsation therapy.
Subscribe to our email newsletter
The patent also provides for a method to automatically release all applied pressure to the atmosphere in the event of a system or power failure as a safety measure to avoid injury to the patient. According to the company, at the start of treatment, the therapist selects the optimal inflation pressure for the patient to comfortably receive effective therapy, the technology then fully controls and maintains, with accuracy, the proper inflation and deflation pressures throughout the treatment.
John Hui, president and CEO of Vasomedical and inventor of the patent, said: “Control and maintenance of optimal pressure during enhanced external counterpulsation (EECP) treatment is essential to the effectiveness of this therapy for the high percentage of patients that may have irregular or premature heart beats. This patent is critical to our ability to produce a completely automatic EECP therapeutic system which is capable of providing maximal safety and effectiveness to patients.”